基本信息
views: 242
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Jamieson specialized in myeloproliferative disorders (MPDs) and leukemia. Myeloproliferative neoplasms are a family of uncommon but not rare degenerative disorders in which the body overproduces blood cells. Myeloproliferative neoplasms can cause many forms of blood clotting including heart attack, stroke, deep venous thrombosis, and pulmonary emboli and can develop into acute myelogenous leukemia. Although some effective treatments are available, they are laden with serious side effects. In addition, individuals can become resistant to the treatments. Dr. Jamieson studies the mutant stem cells and progenitor cells in myeloproliferative neoplasms. These cells can give rise to cancer stem cells. Cancer stem cells may lie low to evade chemotherapy and then activate again later, causing disease progression and resistance to treatment. Her goal is to find more selective, less toxic therapies. In the past two years, Dr. Jamieson’s stem-cell research studies have taken a great leap: from identifying a promising treatment in the laboratory to opening and completing the first clinical trial to target cancer stem cells in humans. This trial is the result of teamwork that has brought together her discoveries in myeloproliferative neoplasms and a local pharmaceutical company’s drug development track.
Research Interests
Papers共 404 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Rebecca A. Shatsky, Hemali Batra-Sharma,Teresa Helsten,Richard B. Schwab,Emily I. Pittman,Minya Pu,Elizabeth Weihe,Emanuela M. Ghia,Laura Z. Rassenti,Alfredo Molinolo, Betty Cabrera,James B. Breitmeyer,
BREAST CANCER RESEARCHno. 1 (2024)
Jason Gotlib,Aaron T Gerds, Peter Abdelmessieh,Haris Ali,Mariana Castells,Andrew Dunbar, Ruth Fein Revell,Tracy I George, Steven Green,Krishna Gundabolu,Elizabeth Hexner,Tania Jain,
Journal of the National Comprehensive Cancer Network : JNCCNno. 2D (2024)
Cancer Researchno. 6_Supplement (2024): 2767-2767
Gregory P. Botta,Joseph Chao, Hong Ma,Michael Hahn, Gloria Sierra,Jie Jia,Amanda Y. Hendrix, Joy V. Nolte Fong, Audrey Ween,Peter Vu,Aaron Miller,Michael Choi,
JOURNAL FOR IMMUNOTHERAPY OF CANCERno. 2 (2024)
Cancer Researchno. 6_Supplement (2024): 1485-1485
Jessica Pham,Jane Isquith,Larisa Balaian,Luisa Ladel,Shuvro P. Nandi, Karla Mack,Inge van der Werf, Emma Klacking, Antonio Ruiz, David Mays, Paul Gamble,Shelby Giza,
biorxiv(2024)
Maria Dolores Rivera,Haoran Zhang, Qingchen Zhou,Jessica Pham,Jane Isquith,Roman Sasik,Adam Mark, Sabina Enlund,Frida Holm,Ma Wenxue,Kathleen Fisch,Dennis Kuo,
Cancer Researchno. 6_Supplement (2024): 5448-5448
Rebecca A. Shatsky, Hemali Batra-Sharma,Teresa Helsten,Richard B. Schwab,Emily I. Pittman,Minya Pu,Elizabeth Weihe,Emanuela M. Ghia,Laura Z. Rassenti,Alfredo Molinolo, Betty Cabrera,James B. Breitmeyer,
Inge van der Werf,Larisa Balaian,Jessica Pham,Wenxue Ma, Athena Mohebbi, Emma Klacking, Antonio Ruiz, Karla Mack, John Mascarenhas,Thomas Whisenant,Ludmil Alexandrov,Sheldon Morris,
Cancer Researchno. 6_Supplement (2024): 263-263
Christina A.M. Jamieson,Jamillah Murtadha,Christopher S. Oh,Michelle T. Muldong,Niloofar Etemadfard,Evodie Koutouan, Young E. Yoon,Sanghee Lee, Oh Kwon, Jong J. Oh, Min S. Kim,Karl Willert,
Cancer Researchno. 6_Supplement (2024): 5967-5967
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn